Financhill
Back

TG Therapeutics 10K Form

Buy
73

TGTX
TG Therapeutics

Last Price:
$41.87
Seasonality Move:
15.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TGTX News And Ratings

See the #1 stock for the next 7 days that we like better than TGTX

TGTX Financial Statistics

Sales & Book Value

Annual Sales: $329M
Cash Flow: $-25.7M
Price / Cash Flow: 53.48
Annual Sales: $1.43
Price / Book: 30

Profitability

EPS (TTM): 0.14000
Net Income (TTM): $23.4M
Gross Margin: $290.5M
Return on Equity: 12.81%
Return on Assets: 5.16%

TG Therapeutics Earnings Forecast

Key TG Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 29 years for TGTX is 88.30%.
  • The Selling, General & Administrative Expenses for TGTX have been equal to 46.90% of Gross Profit Margin.
  • The Research & Development expenses have been 28.66% of Revenue.
  • The Interest Expense is 102.76% of Operating Income.
  • The Net Earning history of TGTX is 7.11% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

TG Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TGTX
CUSIP: 88322Q
Website: tgtherapeutics.com

Debt

Debt-to-Equity Ratio: 1.1
Current Ratio: 6.25
Quick Ratio: 4.85

Price-to-Earnings

Trailing P/E Ratio: 283.13
Forward P/E Ratio: 22.29

TGTX Technical Analysis vs Fundamental Analysis

Buy
73
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics a Buy or a Sell?

  • TG Therapeutics stock is rated a Buy
    The current TG Therapeutics [TGTX] share price is $42.47. The Score for TGTX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.